A detailed history of First Trust Advisors LP transactions in Moderna, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 508,832 shares of MRNA stock, worth $34 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
508,832
Previous 604,346 15.8%
Holding current value
$34 Million
Previous $64.4 Million 6.17%
% of portfolio
0.06%
Previous 0.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $9.67 Million - $15.9 Million
-95,514 Reduced 15.8%
508,832 $60.4 Million
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $24.7 Million - $33.4 Million
-288,970 Reduced 32.35%
604,346 $64.4 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $7.11 Million - $10.7 Million
102,251 Added 12.93%
893,316 $88.8 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $3.84 Million - $5.04 Million
39,807 Added 5.3%
791,065 $81.7 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $9.77 Million - $13.2 Million
82,476 Added 12.33%
751,258 $91.3 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $17.8 Million - $25.8 Million
-130,909 Reduced 16.37%
668,782 $103 Million
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $20.4 Million - $36.3 Million
172,731 Added 27.55%
799,691 $144 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $14.4 Million - $23.7 Million
122,146 Added 24.2%
626,960 $74.1 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $288,022 - $434,234
-2,459 Reduced 0.48%
504,814 $72.1 Million
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $18 Million - $33.4 Million
142,297 Added 38.99%
507,273 $87.4 Million
Q4 2021

Feb 08, 2022

SELL
$225.82 - $368.51 $25.9 Million - $42.2 Million
-114,511 Reduced 23.88%
364,976 $92.7 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $62.7 Million - $137 Million
-282,557 Reduced 37.08%
479,487 $185 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $29.5 Million - $53.4 Million
227,063 Added 42.44%
762,044 $179 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $14.5 Million - $24.7 Million
132,798 Added 33.02%
534,981 $70.1 Million
Q4 2020

Feb 02, 2021

BUY
$65.74 - $169.86 $2.66 Million - $6.87 Million
40,468 Added 11.19%
402,183 $42 Million
Q3 2020

Nov 05, 2020

SELL
$54.34 - $94.85 $2.24 Million - $3.91 Million
-41,219 Reduced 10.23%
361,715 $25.6 Million
Q2 2020

Jul 22, 2020

SELL
$29.67 - $80.0 $1.07 Million - $2.88 Million
-36,012 Reduced 8.2%
402,934 $25.9 Million
Q1 2020

May 06, 2020

BUY
$17.78 - $31.58 $7.8 Million - $13.9 Million
438,946 New
438,946 $13.1 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.